Clinical Trials Directory

Trials / Completed

CompletedNCT01952548

Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
Sponsor
Kowa Research Institute, Inc. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers

Summary

This study will test single doses of the study drug in increasing amounts to see if it is safe.

Conditions

Interventions

TypeNameDescription
DRUGK-312
DRUGPlacebo

Timeline

Start date
2013-05-01
Primary completion
2013-12-01
First posted
2013-09-30
Last updated
2013-12-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01952548. Inclusion in this directory is not an endorsement.